ID   J558L-CD40L
AC   CVCL_B7TP
SY   CD40L-J558L
DR   Wikidata; Q112929891
RX   PubMed=7615009;
RX   PubMed=8760829;
CC   Transfected with: MGI; MGI:88337; Cd40lg.
CC   Transfected with: UniProtKB; P06988; Escherichia coli hisD.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse plasma cell myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3949 ! J558L
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=7615009; DOI=10.1002/eji.1830250646;
RA   Lane P., Burdet C., McConnell F., Lanzavecchia A., Padovan E.;
RT   "CD40 ligand-independent B cell activation revealed by CD40
RT   ligand-deficient T cell clones: evidence for distinct activation
RT   requirements for antibody formation and B cell proliferation.";
RL   Eur. J. Immunol. 25:1788-1793(1995).
//
RX   PubMed=8760829; DOI=10.1084/jem.184.2.747;
RA   Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A.,
RA   Alber G.;
RT   "Ligation of CD40 on dendritic cells triggers production of high
RT   levels of interleukin-12 and enhances T cell stimulatory capacity: T-T
RT   help via APC activation.";
RL   J. Exp. Med. 184:747-752(1996).
//